Home 
CONTACT General Physiology and Biophysics 2023 General Physiology and Biophysics Vol.42, No.4, p. 323–338, 2023
CONTACT General Physiology and Biophysics 2023 General Physiology and Biophysics Vol.42, No.4, p. 323–338, 2023
Journal info
Aims and Scope |
||
Select Journal
Journals
Bratislava Medical Journal Endocrine Regulations General Physiology and Biophysics 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 Neoplasma Acta Virologica Studia Psychologica Cardiology Letters Psychológia a patopsych. dieťaťa Kovove Materialy-Metallic Materials Slovenská hudbaWebshop Cart
Your Cart is currently empty.
Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.
General Physiology and Biophysics Vol.42, No.4, p. 323–338, 2023 |
||
| Title: Biomedical research brings mTBI biomarkers a step closer to the bedside – implementation in clinical practice | ||
| Author: Martina Martinikova, Robert Ruzinak, Egon Kurca, Michael T. Grey, Stefan Sivak | ||
| Abstract: Research in the field of TBI (traumatic brain injury) has long been focused on severe brain injury, while the number of mild injuries far overweigh severe injuries. Mild head injuries constitute up to 95% of all traumatic head injuries. The purpose of this work is to identify mTBI (mild traumatic brain injury) patients who are unlikely to benefit from CT (computed tomography) scanning. Biomarkers capable of clearly discriminating between CT-positive and CT-negative subjects are needed. Biomarkers hold the potential to document whether a concussion occurred, especially when the history is unclear and neurocognitive sequelae persist. Recently, following advances in proteomics analysis, investigators have introduced ubiquitin C-terminal hydrolase-L1 (UCH-L1) and glial fibrillary acidic protein (GFAP) as two promising brain injury biomarkers. The authors provide an update on the current knowledge of TBI biomarkers, especially protein biomarkers for neuronal cell body injury (UCH-L1) and astroglial injury (GFAP, S100B), and a focused literature review dealing with implementation of mTBI biomarkers in clinical practice. |
||
| Keywords: Mild traumatic brain injury — mTBI biomarkers — GFAP — UCH-L1 — S100B | ||
| Published online: 03-Jul-2023 | ||
| Year: 2023, Volume: 42, Issue: 4 | Page From: 323, Page To: 338 | |
| doi:10.4149/gpb_2023013 |
||
|
|
 download file |
|